news

Advance Capital is pleased to announce the completion of an investment round for the Russian medical devices manufacturing plant MedProm Bobeny Production.

Following the investment, the plant plans to reach a target capacity of 450 million syringes per year and become the largest and most technologically advanced medical syringe manufacturing facility.

Evgeny Antipov, Partner and Managing Director at Advance Capital:

“This deal confirms Advance Capital’s unique expertise in raising both equity and debt financing regardless of the economic environment and ongoing market volatility. At present, our team is actively focused on three types of transactions: crisis-resilient and import-substitution projects, special situations, and high-potential early-stage opportunities.”

Advance Capital acted as a financial advisor to MedProm Bobeny Production.

The deal value is not disclosed.